Global Oral Proteins and Peptides Competitive Landscape Professional Research Report 2025
Research Summary
Oral proteins and peptides are biologically active molecules that are administered through oral ingestion, allowing them to be absorbed and exert their therapeutic effects within the human body. These substances can include proteins, peptides, and antibodies designed to treat various medical conditions. Developing effective oral protein and peptide formulations is a significant challenge due to the digestive processes in the gastrointestinal tract. However, research and innovations in drug delivery technologies, such as nanoparticles, oral capsules, and mucoadhesive formulations, have expanded the possibilities of oral administration for these therapeutic molecules. This approach offers the advantage of non-invasive drug delivery and enhanced patient compliance, particularly for long-term treatments, as it eliminates the need for injections or intravenous infusions. It has the potential to revolutionize the treatment of conditions ranging from diabetes to autoimmune diseases, offering more convenient and patient-friendly options for managing various medical disorders.
According to DIResearch's in-depth investigation and research, the global Oral Proteins and Peptides market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Oral Proteins and Peptides include Ironwood & Allergan, Novo Nordisk, Synergy Pharma, Novartis, Amryt Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Oral Proteins and Peptides. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Oral Proteins and Peptides market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Oral Proteins and Peptides market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oral Proteins and Peptides industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Oral Proteins and Peptides Include:
Ironwood & Allergan
Novo Nordisk
Synergy Pharma
Novartis
Amryt Pharma
Oral Proteins and Peptides Product Segment Include:
Linaclotide
Insulin
Plecanatide
Cyclosporine
Octreotide
Oral Proteins and Peptides Product Application Include:
Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Oral Proteins and Peptides Industry PESTEL Analysis
Chapter 3: Global Oral Proteins and Peptides Industry Porter’s Five Forces Analysis
Chapter 4: Global Oral Proteins and Peptides Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Oral Proteins and Peptides Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Oral Proteins and Peptides Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Oral Proteins and Peptides Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Oral Proteins and Peptides Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Oral Proteins and Peptides Product by Type
- 1.2.1 Linaclotide
- 1.2.2 Insulin
- 1.2.3 Plecanatide
- 1.2.4 Cyclosporine
- 1.2.5 Octreotide
- 1.3 Oral Proteins and Peptides Product by Application
- 1.3.1 Gastric & Digestive Disorders
- 1.3.2 Bone Diseases
- 1.3.3 Diabetes
- 1.3.4 Hormonal Disorders
- 1.4 Global Oral Proteins and Peptides Market Revenue and Sales Analysis
- 1.4.1 Global Oral Proteins and Peptides Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Oral Proteins and Peptides Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Oral Proteins and Peptides Market Sales Price Trend Analysis (2020-2032)
- 1.5 Oral Proteins and Peptides Industry Trends and Innovation
- 1.5.1 Oral Proteins and Peptides Industry Trends and Innovation
- 1.5.2 Oral Proteins and Peptides Market Drivers and Challenges
- 2 Oral Proteins and Peptides Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Oral Proteins and Peptides Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Oral Proteins and Peptides Market Analysis by Regions
- 4.1 Oral Proteins and Peptides Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Oral Proteins and Peptides Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Oral Proteins and Peptides Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Oral Proteins and Peptides Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Oral Proteins and Peptides Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Oral Proteins and Peptides Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Oral Proteins and Peptides Sales Forecast by Region (2026-2032)
- 4.4 Global Oral Proteins and Peptides Sales Price Trend Analysis (2020-2032)
- 5 Global Oral Proteins and Peptides Market Size by Type and Application
- 5.1 Global Oral Proteins and Peptides Market Size by Type
- 5.1.1 Global Oral Proteins and Peptides Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Oral Proteins and Peptides Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Oral Proteins and Peptides Market Size by Application
- 5.2.1 Global Oral Proteins and Peptides Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Oral Proteins and Peptides Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Oral Proteins and Peptides Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Oral Proteins and Peptides Market Size by Type
- 6.3.1 North America Oral Proteins and Peptides Sales by Type (2020-2032)
- 6.3.2 North America Oral Proteins and Peptides Revenue by Type (2020-2032)
- 6.4 North America Oral Proteins and Peptides Market Size by Application
- 6.4.1 North America Oral Proteins and Peptides Sales by Application (2020-2032)
- 6.4.2 North America Oral Proteins and Peptides Revenue by Application (2020-2032)
- 6.5 North America Oral Proteins and Peptides Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Oral Proteins and Peptides Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Oral Proteins and Peptides Market Size by Type
- 7.3.1 Europe Oral Proteins and Peptides Sales by Type (2020-2032)
- 7.3.2 Europe Oral Proteins and Peptides Revenue by Type (2020-2032)
- 7.4 Europe Oral Proteins and Peptides Market Size by Application
- 7.4.1 Europe Oral Proteins and Peptides Sales by Application (2020-2032)
- 7.4.2 Europe Oral Proteins and Peptides Revenue by Application (2020-2032)
- 7.5 Europe Oral Proteins and Peptides Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Oral Proteins and Peptides Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Oral Proteins and Peptides Market Size by Type
- 8.3.1 China Oral Proteins and Peptides Sales by Type (2020-2032)
- 8.3.2 China Oral Proteins and Peptides Revenue by Type (2020-2032)
- 8.4 China Oral Proteins and Peptides Market Size by Application
- 8.4.1 China Oral Proteins and Peptides Sales by Application (2020-2032)
- 8.4.2 China Oral Proteins and Peptides Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Oral Proteins and Peptides Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Oral Proteins and Peptides Market Size by Type
- 9.3.1 APAC (excl. China) Oral Proteins and Peptides Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Oral Proteins and Peptides Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Oral Proteins and Peptides Market Size by Application
- 9.4.1 APAC (excl. China) Oral Proteins and Peptides Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Oral Proteins and Peptides Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Oral Proteins and Peptides Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Oral Proteins and Peptides Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Oral Proteins and Peptides Market Size by Type
- 10.3.1 Latin America Oral Proteins and Peptides Sales by Type (2020-2032)
- 10.3.2 Latin America Oral Proteins and Peptides Revenue by Type (2020-2032)
- 10.4 Latin America Oral Proteins and Peptides Market Size by Application
- 10.4.1 Latin America Oral Proteins and Peptides Sales by Application (2020-2032)
- 10.4.2 Latin America Oral Proteins and Peptides Revenue by Application (2020-2032)
- 10.5 Latin America Oral Proteins and Peptides Market Size by Country
- 10.6 Latin America Oral Proteins and Peptides Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Oral Proteins and Peptides Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Oral Proteins and Peptides Market Size by Type
- 11.3.1 Middle East & Africa Oral Proteins and Peptides Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Oral Proteins and Peptides Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Oral Proteins and Peptides Market Size by Application
- 11.4.1 Middle East & Africa Oral Proteins and Peptides Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Oral Proteins and Peptides Revenue by Application (2020-2032)
- 11.5 Middle East Oral Proteins and Peptides Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Oral Proteins and Peptides Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Oral Proteins and Peptides Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Oral Proteins and Peptides Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Oral Proteins and Peptides Average Sales Price by Manufacturers (2021-2025)
- 12.2 Oral Proteins and Peptides Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Oral Proteins and Peptides Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Ironwood & Allergan
- 13.1.1 Ironwood & Allergan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Ironwood & Allergan Oral Proteins and Peptides Product Portfolio
- 13.1.3 Ironwood & Allergan Oral Proteins and Peptides Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 Novo Nordisk
- 13.2.1 Novo Nordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Novo Nordisk Oral Proteins and Peptides Product Portfolio
- 13.2.3 Novo Nordisk Oral Proteins and Peptides Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Synergy Pharma
- 13.3.1 Synergy Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Synergy Pharma Oral Proteins and Peptides Product Portfolio
- 13.3.3 Synergy Pharma Oral Proteins and Peptides Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Novartis
- 13.4.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Novartis Oral Proteins and Peptides Product Portfolio
- 13.4.3 Novartis Oral Proteins and Peptides Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Amryt Pharma
- 13.5.1 Amryt Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Amryt Pharma Oral Proteins and Peptides Product Portfolio
- 13.5.3 Amryt Pharma Oral Proteins and Peptides Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Oral Proteins and Peptides Industry Chain Analysis
- 14.2 Oral Proteins and Peptides Industry Raw Material and Suppliers Analysis
- 14.2.1 Oral Proteins and Peptides Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Oral Proteins and Peptides Typical Downstream Customers
- 14.4 Oral Proteins and Peptides Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook